Post-translational incorporation of the antiproliferative agent azatyrosine into the C-terminus of alpha-tubulin

• Published in: Biochemical journal 2003-10, Vol.375 (Pt 1), p.121-129
• Main Authors: Purro, Silvia A, Bisig, C Gastón, Contin, María A, Barra, Héctor S, Arce, Carlos A
• Format: Article
• Language: English
• Subjects: Alanine - analogs & derivatives; Alanine - metabolism; Alanine - pharmacology; Animals; Antibiotics, Antineoplastic - metabolism; Antibiotics, Antineoplastic - pharmacology; azatyrosine; Brain Chemistry; Carboxypeptidases - metabolism; Cell Division - drug effects; Cell Extracts; Cell Line; Microtubules - metabolism; Microtubules - ultrastructure; Neoplasms, Experimental - metabolism; Neoplasms, Experimental - pathology; Protein Processing, Post-Translational; Rats; Rats, Wistar; Tubulin - chemistry; Tubulin - metabolism; Tumor Cells, Cultured
• ISSN: 0264-6021; 1470-8728
• DOI: 10.1042/BJ20030776

Detyrosination/tyrosination of tubulin is a post-translational modification that occurs at the C-terminus of the alpha-subunit, giving rise to microtubules rich in either tyrosinated or detyrosinated tubulin which coexist in the cell. We hereby report that the tyrosine analogue, azatyrosine, can be incorporated into the C-terminus of alpha-tubulin instead of tyrosine. Azatyrosine is structurally identical to tyrosine except that a nitrogen atom replaces carbon-2 of the phenolic group. Azatyrosine competitively excluded incorporation of [14C]tyrosine into tubulin of soluble brain extract. A newly developed rabbit antibody specific to C-terminal azatyrosine was used to study incorporation of azatyrosine in cultured cells. When added to the culture medium (Ham's F12K), azatyrosine was incorporated into tubulin of glioma-derived C6 cells. This incorporation was reversible, i.e. after withdrawal of azatyrosine, tubulin lost azatyrosine and reincorporated tyrosine. Azatyrosinated tubulin self-assembled into microtubules to a similar degree as total tubulin both in vitro and in vivo. Studies by other groups have shown that treatment of certain types of cultured cancer cells with azatyrosine leads to reversion of phenotype to normal, and that administration of azatyrosine into animals harbouring human proto-oncogenic c-Ha- ras prevents tumour formation. These interesting observations led us to study this phenomenon in relation to tubulin status. Under conditions in which tubulin was mostly azatyrosinated, C6 cells remained viable but did not proliferate. After 7-10 days under these conditions, morphology changed from a fused, elongated shape to a rounded soma with thin processes. Incorporation of azatyrosine into the C-terminus of alpha-tubulin is proposed as one possible cause of reversion of the malignant phenotype.